Feasibility of endoscopic ultrasound-guided fine needle biopsy for generating patient-derived organoids of pancreatic ductal adenocarcinoma: preliminary results from a single-center prospective database
Endoscopy · 01.04.2024 · 56 (S 02 S 02) · S95
DOI: 10.1055/s-0044-1782895 ↗Kurz gefasst
Fachartikel in der Zeitschrift Endoscopy, erschienen am 01.04.2024. Verfasst von F. Borrelli de Andreis und 6 weiteren Autor:innen.
Abstract (Originalsprache)
Aims
Pancreatic ductal adenocarcinoma (PDAC) is notorious for its aggressive nature and grim prognosis, underscoring the urgent need for personalized pre-clinical models to develop targeted therapies. Patient-derived organoids (PDOs) are three-dimensional models of human tumors that have emerged as promising research tools. We therefore aimed to assess the feasibility of endoscopic ultrasound-guided fine needle biopsy (EUS-FNB) for generating PDAC-PDOs.
Methods
A single-center prospective database was established to collect data from suspected PDAC patients undergoing EUS-FNB for histological confirmation between May and October 2023. All biopsies were performed using a 22G-needle. Two to three biopsies were taken for histological examination before performing a single-pass FNB to establish PDO cultures. The primary outcome was the successful propagation of PDAC-PDOs for at least three passages (P3). Secondary outcomes included sample adequacy, diagnostic rate, and safety.
Results
A total of 22 patients (M:F 13:9, median age 66.5 years, range 55-86) were enrolled. One case was subsequently diagnosed as pancreatic lymphoma and excluded. PDAC-PDOs were successfully established in 9 out of 21 PDAC cases at P3, resulting in a success rate of 43%. The median size of the 9 PDAC from which PDOs were generated was 4 cm (range 1.2-5). 5 masses were located in the pancreatic head, 1 in the neck, 1 in the body, and 2 in the tail. Sample adequacy and diagnostic rates were both achieved in 100% of subjects. The presence of a biliary stent during EUS-FNB did not impact the success rate of PDAC-PDO generation (n=1 in the generated PDAC-PDOs group vs n=3 in the non-generated PDAC-PDOs group; p =0.254). No adverse events related to the procedure occurred. [ 1 ]
Conclusions
This study demonstrates that PDAC-PDOs can be successfully generated through EUS-FNB sampling with a single-pass fine needle biopsy, without compromising the safety profile of the procedure. Publication History Article published online: 15 April 2024 © 2024. European Society of Gastrointestinal Endoscopy. All rights reserved. Georg Thieme Verlag KG Rüdigerstraße 14, 70469 Stuttgart, Germany
Zitieren
APA
Andreis, F. B. D., Panzeri, V., Ruta, V., Cesari, E., Attili, F., Spada, C., & Sette, C. (2024). Feasibility of endoscopic ultrasound-guided fine needle biopsy for generating patient-derived organoids of pancreatic ductal adenocarcinoma: preliminary results from a single-center prospective database. Endoscopy, 56(S 02 S 02), S95. https://doi.org/10.1055/s-0044-1782895
Vancouver
Andreis FBD, Panzeri V, Ruta V, Cesari E, Attili F, Spada C, et al. Feasibility of endoscopic ultrasound-guided fine needle biopsy for generating patient-derived organoids of pancreatic ductal adenocarcinoma: preliminary results from a single-center prospective database. Endoscopy. 2024;56(S 02 S 02):S95. doi:10.1055/s-0044-1782895
BibTeX
@article{Andreis2024,
author = {Andreis, F. Borrelli de and Panzeri, V. and Ruta, V. and Cesari, E. and Attili, F. and Spada, C. and Sette, C.},
title = {Feasibility of endoscopic ultrasound-guided fine needle biopsy for generating patient-derived organoids of pancreatic ductal adenocarcinoma: preliminary results from a single-center prospective database},
journal = {Endoscopy},
year = {2024},
volume = {56},
number = {S 02 S 02},
pages = {S95},
doi = {10.1055/s-0044-1782895}
}
EUVIMED